Literature DB >> 28428219

Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.

Jifeng Zhang1, Manabu Niimi2, Dongshan Yang2, Jingyan Liang2, Jie Xu2, Tokuhide Kimura2, Anna V Mathew2, Yanhong Guo2, Yanbo Fan2, Tianqing Zhu2, Jun Song2, Rose Ackermann2, Yui Koike2, Anna Schwendeman2, Liangxue Lai2, Subramaniam Pennathur2, Minerva Garcia-Barrio2, Jianglin Fan1, Y Eugene Chen1.   

Abstract

OBJECTIVE: CETP (cholesteryl ester transfer protein) plays an important role in lipoprotein metabolism; however, whether inhibition of CETP activity can prevent cardiovascular disease remains controversial. APPROACH AND
RESULTS: We generated CETP knockout (KO) rabbits by zinc finger nuclease gene editing and compared their susceptibility to cholesterol diet-induced atherosclerosis to that of wild-type (WT) rabbits. On a chow diet, KO rabbits showed higher plasma levels of high-density lipoprotein (HDL) cholesterol than WT controls, and HDL particles of KO rabbits were essentially rich in apolipoprotein AI and apolipoprotein E contents. When challenged with a cholesterol-rich diet for 18 weeks, KO rabbits not only had higher HDL cholesterol levels but also lower total cholesterol levels than WT rabbits. Analysis of plasma lipoproteins revealed that reduced plasma total cholesterol in KO rabbits was attributable to decreased apolipoprotein B-containing particles, while HDLs remained higher than that in WT rabbits. Both aortic and coronary atherosclerosis was significantly reduced in KO rabbits compared with WT rabbits. Apolipoprotein B-depleted plasma isolated from CETP KO rabbits showed significantly higher capacity for cholesterol efflux from macrophages than that from WT rabbits. Furthermore, HDLs isolated from CETP KO rabbits suppressed tumor necrosis factor-α-induced vascular cell adhesion molecule 1 and E-selectin expression in cultured endothelial cells.
CONCLUSIONS: These results provide evidence that genetic ablation of CETP activity protects against cholesterol diet-induced atherosclerosis in rabbits.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  apolipoprotein; atherosclerosis; cholesterol reduction; cholesteryl ester transfer protein genetics; high-density lipoprotein

Mesh:

Substances:

Year:  2017        PMID: 28428219      PMCID: PMC5805397          DOI: 10.1161/ATVBAHA.117.309114

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

1.  CETP and atherosclerosis.

Authors:  P Barter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

2.  Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.

Authors:  John J P Kastelein; Joost Besseling; Sukrut Shah; Jean Bergeron; Gisle Langslet; G Kees Hovingh; Naab Al-Saady; Michiel Koeijvoets; John Hunter; Amy O Johnson-Levonas; Jennifer Fable; Aditi Sapre; Yale Mitchel
Journal:  Lancet       Date:  2015-03-03       Impact factor: 79.321

3.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

Authors:  A Inazu; M L Brown; C B Hesler; L B Agellon; J Koizumi; K Takata; Y Maruhama; H Mabuchi; A R Tall
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

4.  Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis.

Authors:  C W Rittershaus; D P Miller; L J Thomas; M D Picard; C M Honan; C D Emmett; C L Pettey; H Adari; R A Hammond; D T Beattie; A D Callow; H C Marsh; U S Ryan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

5.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

6.  A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits.

Authors:  H Okamoto; F Yonemori; K Wakitani; T Minowa; K Maeda; H Shinkai
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

7.  Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia.

Authors:  Zhiping Huang; Akihiro Inazu; Atsushi Nohara; Toshinori Higashikata; Hiroshi Mabuchi
Journal:  Clin Sci (Lond)       Date:  2002-12       Impact factor: 6.124

8.  Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.

Authors:  K R Marotti; C K Castle; T P Boyle; A H Lin; R W Murray; G W Melchior
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

9.  Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case.

Authors:  Philip J Barter; Stephen J Nicholls; John J P Kastelein; Kerry-Anne Rye
Journal:  Circulation       Date:  2015-08-04       Impact factor: 29.690

10.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.

Authors:  P T Kovanen; M S Brown; S K Basu; D W Bilheimer; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more
  23 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.

Authors:  Feiming Ye; Ya Wang; Congqing Wu; Deborah A Howatt; Chia-Hua Wu; Anju Balakrishnan; Adam E Mullick; Mark J Graham; A H Jan Danser; Jian'an Wang; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

Review 3.  High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.

Authors:  Yi He; Vishal Kothari; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

4.  Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.

Authors:  Yunosuke Matsuura; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

5.  Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits.

Authors:  Omnia A A Nour; George S G Shehatou; Mona Abdel Rahim; Mohammed S El-Awady; Ghada M Suddek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

6.  Updates on Approaches for Studying Atherosclerosis.

Authors:  Congqing Wu; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

7.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 8.  HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.

Authors:  Cecilia Vitali; Sumeet A Khetarpal; Daniel J Rader
Journal:  Curr Cardiol Rep       Date:  2017-11-04       Impact factor: 2.931

Review 9.  Rabbit models of human diseases for diagnostics and therapeutics development.

Authors:  Rose G Mage; Pedro J Esteves; Christoph Rader
Journal:  Dev Comp Immunol       Date:  2018-10-16       Impact factor: 3.636

Review 10.  Trials and Tribulations of CETP Inhibitors.

Authors:  Alan R Tall; Daniel J Rader
Journal:  Circ Res       Date:  2017-10-10       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.